AGN News and Press, Allergan plc From 05/15/19

Evolus ( EOLS ) is a one drug company that is gearing up to enter the personal aesthetics arena. They look to compete against the market leader, Allergan ( AGN ), with their own version of Botox, which will be branded as Jeuveau in the US. They have also recently received a positive opinion ...

DUBLIN , May 15, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it will showcase data during the upcoming American Psychiatric Association (APA) Annual Meeting in San Francisco , May 18 – May 22, 2019 . Data being pr...

Commercial Study Will Measure Impact of Increasing Access and Affordability of Aesthetic Procedures PatientFi, LLC, a leading financial technology company that partners with medical practices to offer patients accessible financing plans for elective procedures, is pleased to announce ...

The FDA has completed its long-anticipated guidance on interchangeability of biosimilars, allowing their substitution for reference biologics without prescribers' sign-off. More news on: AbbVie Inc., ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Tru...

STATnews reports that the new price disclosure requirement in the U.S., expected to go into effect in about 60 days, should only affect a subset of Big Biopharma members since some do not routinely advertise on television. More news on: Pfizer Inc., AbbVie Inc., Eli Lilly and Company, He...

On 3/5/19 we published a bearish report on T2 Biosystems ( TTOO ) with a 12-month target of $1.50. However, that target now looks conservative. We now believe TTOO could tumble to around $0.50 within a year, similar to how Viveve Medical ( VIVE ) has tumbled lower than our $0.90 price targe...

DUBLIN , May 9, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Financial Officer Matthew Walsh will participate in a fireside chat at the Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas , Nevada. The presentation will begin at 10:4...

In lockstep with the U.S., Canadian officials are poised to implement a new initiative aimed at corralling high prescription drug costs, despite an offer by drug makers to pay C$8.6B (US$6.6B) over 10 years, freeze prices or reduce the cost of treating rare diseases. More news on: ProSha...

Today's Top Stories: Equities try to steady after selloff; Iran begins withdrawal from nuclear deal; and pound on edge as support builds to oust May. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Wall Street is looking to stabilize following last night's 473 point fall for the DJIA, as Chinese t...